Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,225
datasets available to search
ShareScore release 0.9.0
Dataset results
5,225 results for “moderation”
Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis
ClinicalTrials.gov study NCT03049267. IPD Sharing: NO. Countries: 1. Publications: 0.
Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function
ClinicalTrials.gov study NCT00626249. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluate the Pharmacokinetics of CC-220 in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared With Healthy Subjects
ClinicalTrials.gov study NCT03824678. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With Moderate-to-Severe Atopic Hand and Foot Dermatitis
ClinicalTrials.gov study NCT06921759. IPD Sharing: YES. Countries: 8. Publications: 0.
Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma
ClinicalTrials.gov study NCT00624702. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase III, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of TD0069 Capsule for Patients With Mild to Moderate COVID-19
ClinicalTrials.gov study NCT05249777. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease
ClinicalTrials.gov study NCT05639192. IPD Sharing: Not stated. Countries: 9. Publications: 0.
VTX958 Versus Placebo for the Treatment of Moderate to Severe Psoriasis
ClinicalTrials.gov study NCT05655299. IPD Sharing: UNDECIDED. Countries: 3. Publications: 0.
Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19
ClinicalTrials.gov study NCT04362332. IPD Sharing: YES. Countries: 1. Publications: 0.
The Efficacy and Safety of CUNOX® in Patients With Moderate to Severe Glabellar Lines
ClinicalTrials.gov study NCT03837561. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients
ClinicalTrials.gov study NCT06946641. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Safety and Efficacy of MoodElite T-4003-1 on Improving Mood in a Healthy Adult Population With Mild to Moderate Depressive Symptoms Not Eligible for Therapeutic Intervention
ClinicalTrials.gov study NCT05318456. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia
ClinicalTrials.gov study NCT02100202. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE)
ClinicalTrials.gov study NCT04229836. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Phase I, Prospective, Randomized, Open-label, Active-Controlled Clinical Trial for Safety Evaluation of Intra-articular Injection of RegenoGel-SP for the Treatment of Moderate to Severe Osteoarthrit
ClinicalTrials.gov study NCT02188771. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma
ClinicalTrials.gov study NCT01362621. IPD Sharing: Not stated. Countries: 2. Publications: 0.
An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease
ClinicalTrials.gov study NCT00097916. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azilsartan in Chinese Patients With Mild and Moderate Hypertension
ClinicalTrials.gov study NCT02609490. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetics and Safety Assessment of VX-121/Tezacaftor/Deutivacaftor in Participants With Moderate Hepatic Impairment
ClinicalTrials.gov study NCT05437120. IPD Sharing: NO. Countries: 1. Publications: 0.
BreEStim for Motor Recovery in Chronic Stroke With Moderate Impairment (Pilot).
ClinicalTrials.gov study NCT04750551. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.